[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Vahabi et al., 2011 - Google Patents

Correlation between interleukin-1β, interleukin-6 and tumor necrosis factor-α and clinical parameters in chronic and aggressive periodontal disease

Vahabi et al., 2011

View PDF
Document ID
12488724814805637934
Author
Vahabi S
Sattari M
Taheraslani M
Bagheban A
Publication year
Publication venue
Journal of Advanced Periodontology & Implant Dentistry

External Links

Snippet

Background and aims. It has been reported that Type I hypersensitivity plays an important role in periodontal diseases. The aim of this study was to investigate the possible correlation between interleukin-1β, IL-6, and tumor necrosis factor-α as immunologic mediators and …
Continue reading at japid.tbzmed.ac.ir (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2026—IL-4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • A61K2039/55527—Interleukins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2

Similar Documents

Publication Publication Date Title
Ata-Ali et al. Clinical, microbiological, and immunological aspects of healthy versus peri-implantitis tissue in full arch reconstruction patients: a prospective cross-sectional study
Gong et al. Clinical, microbiologic, and immunologic factors of orthodontic treatment-induced gingival enlargement
Jakovljevic et al. Pro‐inflammatory cytokine levels in human apical periodontitis: correlation with clinical and histological findings
Duarte et al. Effect of anti‐infective mechanical therapy on clinical parameters and cytokine levels in human peri‐implant diseases
Qadri et al. The short‐term effects of low‐level lasers as adjunct therapy in the treatment of periodontal inflammation
Darabi et al. Comparison of the levels of tumor necrosis factor-α and interleukin-17 in gingival crevicular fluid of patients with peri-implantitis and a control group with healthy implants
Robati et al. Detection of IL-4, IL-6 and IL-12 serum levels in generalized aggressive periodontitis
Talmac et al. Effects of Er, Cr: YSGG and Diode Lasers on Clinical Parameters and Gingival Crevicular Fluid IL‐1β and IL‐37 Levels in Generalized Aggressive Periodontitis
Liu et al. Relationships between clinical parameters, Interleukin 1B and histopathologic findings of gingival tissue in periodontitis patients
Santamaria et al. Connective tissue graft plus resin-modified glass ionomer restoration for the treatment of gingival recession associated with non-carious cervical lesions: microbiological and immunological results
Vahabi et al. Correlation between interleukin-1β, interleukin-6 and tumor necrosis factor-α and clinical parameters in chronic and aggressive periodontal disease
Jarry et al. Secreted osteoclastogenic factor of activated T cells (SOFAT), a novel osteoclast activator, in chronic periodontitis
Seemann et al. Levels of parotid and submandibular/sublingual salivary immunoglobulin A in response to experimental gingivitis in humans
Sattari et al. Effect of surgical flap on IL-1β and TGF-β concentrations in the gingival crevicular fluid of patients with moderate to severe chronic periodontitis
Degasperi et al. Periodontal disease: general aspects from biofilm to the immune response driven by periodontal pathogens
Bulut et al. Expression of caspase-3, p53 and Bcl-2 in generalized aggressive periodontitis
Huang et al. Role of periodontal ligament fibroblasts in periodontitis: pathological mechanisms and therapeutic potential
Türkoğlu et al. The effect of adjunctive chlorhexidine mouthrinse on clinical parameters and gingival crevicular fluid cytokine levels in untreated plaque-associated gingivitis
Liu et al. In vitro effect of laser irradiation on cementum‐bound endotoxin isolated from periodontally diseased roots
Schiefelbein et al. Periodontal Conditions during Arthritis Therapy with TNF-α Blockers.
Mohammad Effect of periodontal therapy on salivary total protein, TNF-alpha and IL-1 beta in chronic periodontitis patients
Sreedhar et al. Efficacy of Propolis as an Adjunct to Scaling and Root planing in patients with chronic periodontitis-placebo controlled study.
Aydın et al. Measurement of oncostatin M, leukemia inhibitory factor, and interleukin-11 levels in serum, saliva, and gingival crevicular fluid of patients with periodontal diseases
Mohammadi Association of Inflammatory Markers and Growth Factors with Radiographically Assessed Wound Healing of Extraction Sockets
Al-Obadi et al. Evolution of Salivary Osteoprotegerin OPG and RANKLE after using Probiotics in Diabetic Patients Type 2 with Periodontitis